{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:42:25Z","timestamp":1783618945946,"version":"3.55.0"},"reference-count":43,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1532,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1600-0609.2011.01623.x","type":"journal-article","created":{"date-parts":[[2011,4,11]],"date-time":"2011-04-11T12:43:15Z","timestamp":1302525795000},"page":"73-79","source":"Crossref","is-referenced-by-count":40,"title":["Health-related quality of life in adults with transfusion-independent thalassaemia intermedia compared to regularly transfused thalassaemia major: new insights"],"prefix":"10.1111","volume":"87","author":[{"given":"Khaled M.","family":"Musallam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Abi-Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama","family":"Bazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Succar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Racha","family":"Halawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hankir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Koussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali T.","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,6,22]]},"reference":[{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB1|cit1","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511596582","volume-title":"Disorders of Hemoglobin: Genetics Pathophysiology, and Clinical Management","author":"Steinberg","year":"2009"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB2|cit2","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199409013310903","article-title":"Survival in medically treated patients with homozygous beta-thalassemia","volume":"331","author":"Olivieri","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1196\/annals.1345.035","article-title":"Quality of life in thalassemia","volume":"1054","author":"Telfer","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl. 1","key":"10.1111\/j.1600-0609.2011.01623.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.3109\/03630260903351528","article-title":"Insight onto the pathophysiology and clinical complications of thalassemia intermedia","volume":"33","author":"Cappellini","year":"2009","journal-title":"Hemoglobin"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2141.2010.08220.x","article-title":"Age-related complications in treatment-naive patients with thalassaemia intermedia","volume":"150","author":"Taher","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","article-title":"Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study","volume":"115","author":"Taher","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0268-960X(98)90014-5","article-title":"Severe thalassaemia intermedia: clinical problems in the absence of hypertransfusion","volume":"12","author":"Mohamed","year":"1998","journal-title":"Blood Rev"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB9|cit9","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2010.08486.x","article-title":"Optimal management of beta thalassaemia intermedia","author":"Taher","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB10|cit10","first-page":"58","article-title":"Thalassemia intermedia","volume":"80","author":"Camaschella","year":"1995","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1016\/j.jacc.2004.02.032","article-title":"Diagnosis and differential assessment of pulmonary arterial hypertension","volume":"43","author":"Barst","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/hrt.67.4.289","article-title":"Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial","volume":"67","author":"Kleber","year":"1992","journal-title":"Br Heart J"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4158\/1934-2403-8.6.457","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism","volume":"8","author":"Baskin","year":"2002","journal-title":"Endocr Pract"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jocd.2008.02.006","article-title":"First update of the Lebanese guidelines for osteoporosis assessment and treatment","volume":"11","author":"El-Hajj Fuleihan","year":"2008","journal-title":"J Clin Densitom"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2141.2006.06332.x","article-title":"Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease","volume":"135","author":"Fung","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1477-7525-1-30","article-title":"Quality of life in rural and urban populations in Lebanon using SF-36 health survey","volume":"1","author":"Sabbah","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB18|cit18","volume-title":"Quality of Life and Pharmacoeconomics in Clinical Trials","author":"Spilker","year":"1996"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2326-10-1","article-title":"Factors affecting health-related quality of life in Thai children with thalassemia","volume":"10","author":"Thavorncharoensap","year":"2010","journal-title":"BMC Blood Disord"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2214.2009.01043.x","article-title":"Health-related quality of life and financial impact of caring for a child with Thalassaemia Major in the UK","volume":"36","author":"Clarke","year":"2010","journal-title":"Child Care Health Dev"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s12098-007-0127-6","article-title":"Psychological problems and quality of life in children with thalassemia","volume":"74","author":"Shaligram","year":"2007","journal-title":"Indian J Pediatr"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-7525-4-39","article-title":"Health Related Quality of Life in Malaysian children with thalassaemia","volume":"4","author":"Ismail","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.adolescence.2003.11.011","article-title":"Brief report: depressive symptoms and quality of life in adolescents with b-thalassaemia","volume":"27","author":"Mikelli","year":"2004","journal-title":"J Adolesc"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB24|cit24","first-page":"794","article-title":"Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment","volume":"50","author":"Dahlui","year":"2009","journal-title":"Singapore Med J"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0022-3859.41432","article-title":"Quality of life in thalassemia major: reliability and validity of the Persian version of the SF-36 questionnaire","volume":"54","author":"Jafari","year":"2008","journal-title":"J Postgrad Med"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11739-008-0166-7","article-title":"Psychosocial aspects and psychiatric disorders in young adult with thalassemia major","volume":"3","author":"Messina","year":"2008","journal-title":"Intern Emerg Med"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1185\/03007990802160834","article-title":"Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study","volume":"24","author":"Scalone","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ajh.21896","article-title":"Quality of life in thalassemia: a comparison of SF-36 results from the thalassemia longitudinal cohort to reported literature and the US norms","volume":"86","author":"Sobota","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"e1426","DOI":"10.1542\/peds.2007-1944","article-title":"Challenges associated with prolonged survival of patients with thalassemia: transitioning from childhood to adulthood","volume":"121","author":"Musallam","year":"2008","journal-title":"Pediatrics"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1196\/annals.1345.059","article-title":"Quality of life in patients with thalassemia intermedia compared to thalassemia major","volume":"1054","author":"Pakbaz","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1111\/j.1537-2995.2007.01416.x","article-title":"Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review","volume":"47","author":"Delea","year":"2007","journal-title":"Transfusion"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/j.1537-2995.2007.01398.x","article-title":"Clinical and economic burden of infused iron chelation therapy in the United States","volume":"47","author":"Payne","year":"2007","journal-title":"Transfusion"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000313447","article-title":"Improved treatment satisfaction and convenience with deferasirox in iron-overloaded patients with beta-Thalassemia: results from the ESCALATOR Trial","volume":"123","author":"Taher","year":"2010","journal-title":"Acta Haematol"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1163\/15685590160141369","article-title":"Effect of oral iron chelation therapy with deferiprone (L1) on the psychosocial status of thalassaemia patients","volume":"31","author":"Zahed","year":"2002","journal-title":"Haematologia (Budap)"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/pbc.22497","article-title":"Health-related quality of life in children with sickle cell disease: a report from the Comprehensive Sickle Cell Centers Clinical Trial Consortium","volume":"55","author":"Dampier","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1160\/TH06-05-0267","article-title":"Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran","volume":"96","author":"Taher","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1537-2995.2007.01192.x","article-title":"Thalassemia intermedia today: should patients regularly receive transfusions?","volume":"47","author":"Aessopos","year":"2007","journal-title":"Transfusion"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1538-7836.2010.03940.x","article-title":"Splenectomy and thrombosis: the case of thalassemia intermedia","volume":"8","author":"Taher","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1538-7836.2009.03651.x","article-title":"Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia","volume":"8","author":"Taher","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2141.2009.07848.x","article-title":"Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies","volume":"147","author":"Taher","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1749-6632.1998.tb10493.x","article-title":"Psychosocial integration of adolescents and young adults with thalassemia major","volume":"850","author":"Di Palma","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/pbc.21974","article-title":"Transition of patients with sickle cell disease from pediatric to adult care: assessing patient readiness","volume":"52","author":"McPherson","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/j.1600-0609.2011.01623.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2010.05598.x","article-title":"Health care transition in thalassemia: pediatric to adult-oriented care","volume":"1202","author":"Levine","year":"2010","journal-title":"Ann NY Acad Sci"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2011.01623.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0609.2011.01623.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T01:52:34Z","timestamp":1712368354000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2011.01623.x"}},"subtitle":["HR-QoL in TI vs. TM"],"short-title":[],"issued":{"date-parts":[[2011,6,22]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01623.x","relation":{},"ISSN":["0902-4441"],"issn-type":[{"value":"0902-4441","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,22]]}}}